25th Anniversary Congress Berlin, Germany
Berlin Congress Centre bcc 17 to 20 October 2017
ESGCT SOCIETY MEMBERSHIP
Registration for ESGCT annual meeting in collaboration with DG-GT e.V.
More information on the programme and practicalities are available on the Berlin page.
First FDA approval for CAR-T cell therapy
First report of JCAR017 trial: CAR-T cell activity observed in the brain
Step forward for gene editing in human embryos
Mechanoresponsive stem cells target cancer metastases
Gene addition of micro-dystrophin improves Duchenne muscular dystrophy symptoms in dogs
Proof of concept for new strategy of genome editing to correct splice-site mutations
Step forward for precision medicine - personalised anti-cancer vaccine tested in patients
Genome editing used to treat Huntington's disease in mice
New developments in blood cell therapy
First clinical trial with in vivo genome editing
Phase I trial of gene therapy for age-related macular degeneration completed
ESGCT welcomes two Student Board Members
Feng Zhang Discusses CRISPR and Future of Gene Editing in Interview in Human Gene Therapy
New gene therapy success in a rare disease of the immune system: Wiskott-Aldrich syndrome
First stem-cell therapy recommended for approval in EU
International head and neck cancer symposia - January 25-27, Essen
FASEB SRC on Genome Engineering - June 24-29, Florence
Innovations in Oncology: 3rd International Symposium
Research assistant position at Royal Holloway, London
Clinical application of CAR T-cells
Do you want to see your job posted here?
CRISPR, ready, go!!
A step towards treatment of congenital deafness with gene therapy
Treating allergy with a single vaccine?
Involving patients in research, we can and should
Copyright ©2016 European Society for Gene and Cell Therapy | Website by OFEC